fluorescent tobacco mosaic virus-derived bio-nanoparticles for intravital two-photon imaging
Clicks: 122
ID: 251860
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
120 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Multi-photon intravital imaging has become a powerful tool to investigate the healthy and diseased brain vasculature in living animals. Although agents for multi-photon fluorescence microscopy of the microvasculature are available, issues related to stability, bioavailability, toxicity, cost or chemical adaptability remain to be solved. In particular, there is a need for highly fluorescent dyes linked to particles that do not cross the blood brain barrier (BBB) in brain diseases like tumor or stroke to estimate the functional blood supply. Plant virus particles possess a number of distinct advantages over other particles, the most important being the multi-valency of chemically addressable sites on the particle surface. This multi-valency, together with biological compatibility and inert nature, makes plant viruses ideal carriers for in vivo imaging agents. Here, we show that the well-known Tobacco mosaic virus is a suitable nanocarrier for two-photon dyes and for intravital imaging of the mouse brain vasculature.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (149 words).
Try re-searching for a better abstract.
| Reference Key |
eniehl2016frontiersfluorescent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Annette eNiehl;Florence eAppaix;Sonia eBoscá;Boudewijn evan der Sanden;Jean-François eNicoud;Frédéric eBolze;Manfred eHeinlein |
| Journal | phytochemistry letters |
| Year | 2016 |
| DOI |
10.3389/fpls.2015.01244
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.